Screener
Rigel Pharmaceuticals RIGL Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The source filing: Rigel Pharmaceuticals’s 10-K, filed March 3, 2026.
- Filed
- Mar 3, 2026, 4:06 PM EST
- Fiscal year
- FY2025
- Accession
- 0001034842-26-000015
| Line item | As of December 31, 2025 | As of December 31, 2024 |
|---|---|---|
| Total liabilities | 122,114 | 160,688 |
| Commitments | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value; 10,000,000 shares authorized; none issued and outstanding as of December 31, 2025 and 2024 | — | — |
| Common stock, $0.001 par value; 400,000,000 shares authorized; 18,310,934 and 17,710,216 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 18 | 18 |
| Additional paid-in capital | 1,414,322 | 1,393,325 |
| Accumulated other comprehensive income | 181 | 10 |
| Accumulated deficit | (1,023,041) | (1,390,065) |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Rigel Pharmaceuticals's preferred stock, shares authorized?
- Rigel Pharmaceuticals (RIGL) reported preferred stock, shares authorized of $10M in Q4 2025.
Ask your AI about Rigel Pharmaceuticals's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude